L-145-2023

Agreement ID
L-145-2023
Lead IC
NCATS
Exclusivity
Nonexclusive
External Party
Life Technologies Corporation
Fiscal Year
2023
Territory
Worldwide
Execution Date
Effective Date
Export Date
Technologies
TAB-3471     Improved Cell Survival and Differentiation of Human Pluripotent Stem Cells by Combining Small Molecules Chroman-1 and Emricasan